IFC:TSXIntact Financial Corporation Analysis
Data as of 2026-05-13 - not real-time
CA$248.65
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Intact Financial Corp (IFC) trades at CAD 248.65, roughly 26% below its DCF‑derived fair value of CAD 386.36, indicating a sizable upside. The stock’s trailing P/E of 13.25 is well under the industry average of 16.64, reinforcing the undervaluation thesis. A forward‑looking P/E of 13.18 and a price‑to‑book multiple of 2.22 further support a value orientation. The company delivers a 2.36% dividend yield on a modest 29% payout ratio, suggesting the dividend is comfortably sustainable. Recent corporate actions—including an 11% dividend increase, a CAD 500 million note issuance, and a renewed share‑buyback program—provide additional upside catalysts. Revenue growth of 4.5% and operating margins near 17% underscore solid earnings momentum.
On the technical side, the price sits just above the calculated support of CAD 245.34 but below the 20‑day SMA (CAD 257.36) and the 50‑day SMA (CAD 254.33). The 14‑day RSI at 40.5 hints at mild oversold pressure, while the MACD histogram remains negative, signaling short‑term bearish momentum. Volatility over the past 30 days is about 21%, and the beta is effectively neutral, implying limited market‑wide price swings. The maximum historical drawdown of roughly 23% is a reminder of the sector’s exposure to catastrophe losses. Overall, the blend of a strong balance sheet (debt‑to‑equity 23.3%), robust free cash flow, and a low‑beta profile tempers the risk picture. Given the “Extreme Greed” sentiment in the fear‑greed index, investors may be underpricing the stock’s defensive attributes.
On the technical side, the price sits just above the calculated support of CAD 245.34 but below the 20‑day SMA (CAD 257.36) and the 50‑day SMA (CAD 254.33). The 14‑day RSI at 40.5 hints at mild oversold pressure, while the MACD histogram remains negative, signaling short‑term bearish momentum. Volatility over the past 30 days is about 21%, and the beta is effectively neutral, implying limited market‑wide price swings. The maximum historical drawdown of roughly 23% is a reminder of the sector’s exposure to catastrophe losses. Overall, the blend of a strong balance sheet (debt‑to‑equity 23.3%), robust free cash flow, and a low‑beta profile tempers the risk picture. Given the “Extreme Greed” sentiment in the fear‑greed index, investors may be underpricing the stock’s defensive attributes.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near support with bearish MACD
- recent dividend hike improves yield
- valuation gap present but short‑term momentum weak
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- undervaluation versus DCF fair value
- strong cash flow and low payout ratio
- share buyback adds return potential
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- stable insurance franchise with low beta
- sustainable dividend and payout discipline
- long‑term upside to fair value target
Key Metrics & Analysis
Financial Health
Revenue Growth4.50%
Profit Margin13.06%
P/E Ratio13.2
ROE17.19%
ROA5.14%
Debt/Equity23.33
P/B Ratio2.2
Op. Cash FlowCA$4.2B
Free Cash FlowCA$4.3B
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI40.5
SupportCA$245.34
ResistanceCA$263.99
MA 20CA$257.36
MA 50CA$254.33
MA 200CA$268.11
MACDBearish
VolumeStable
Fear & Greed Index89.55
Valuation
Fair ValueCA$386.36
Target PriceCA$313.92
Upside/Downside26.25%
GradeUndervalued
TypeValue
Dividend Yield2.36%
Risk Assessment
Beta-0.00
Volatility20.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.